In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

BACKGROUND: Outbreak of Corona Virus Disease in late 2019 (COVID-19) has become a pandemic global Public health emergency. Since there is no approved anti-viral drug or vaccine declared for the disease and investigating existing drugs against the COVID-19. OBJECTIVE: AYUSH-64 is an Ayurvedic formula...

Descripción completa

Detalles Bibliográficos
Autores principales: Ram, Thrigulla Saketh, Munikumar, Manne, Raju, Vankudavath Naik, Devaraj, Parasannanavar, Boiroju, Naveen Kumar, Hemalatha, Rajkumar, Prasad, P.V.V., Gundeti, Manohar, Sisodia, Brijesh S., Pawar, Sharad, Prasad, G.P., Chincholikar, Mukesh, Goel, Sumeet, Mangal, Anupam, Gaidhani, Sudesh, Srikanth, N., Dhiman, K.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article (Experimental)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906523/
https://www.ncbi.nlm.nih.gov/pubmed/33654345
http://dx.doi.org/10.1016/j.jaim.2021.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906523/
https://www.ncbi.nlm.nih.gov/pubmed/33654345
http://dx.doi.org/10.1016/j.jaim.2021.02.004

Ejemplares similares